Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 8/2005

Content (10 Articles)

Original Article

G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell

Eiji Tahara Jr, Hidetoshi Tahara, Masamoto Kanno, Kazuhito Naka, Yayoi Takeda, Takeshi Matsuzaki, Ryuta Yamazaki, Hiroto Ishihara, Wataru Yasui, J Carl Barrett, Toshinori Ide, Eiichi Tahara

Original Article

Immuno-gene therapy of melanoma by tumor antigen epitope modified IFN-γ

Xianghui He, Phoebe Luo, Tom C Tsang, Tong Zhang, David T Harris

Original Article

CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors

Jasmin Dittmann, Karin Keller-Matschke, Toni Weinschenk, Thomas Kratt, Tobias Heck, Horst-Dieter Becker, Stefan Stevanović, Hans-Georg Rammensee, Cécile Gouttefangeas

Original Article

Retrovirus mediated gene transduction of human T-cell subsets

Ida Aagård Hedfors, Karen Johanne Beckstrøm, Claudia Benati, Chiara Bonini, Jan E. Brinchmann

Original Article

Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses

Thomas Felzmann, Katharina Gabriele Hüttner, Sabine Konstanze Breuer, Doris Wimmer, Gabriele Ressmann, Dagmar Wagner, Petra Paul, Manfred Lehner, Andreas Heitger, Wolfgang Holter

Original Article

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

Alessandro Ottaiano, Antonella di Palma, Maria Napolitano, Carmen Pisano, Sandro Pignata, Fabiana Tatangelo, Gerardo Botti, Angela Maria Acquaviva, Giuseppe Castello, Paolo Antonio Ascierto, Rosario Vincenzo Iaffaioli, Stefania Scala

Original Article

Treatment of stage III–IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2

John J. L. Jacobs, Gerrit J. Hordijk, Ina M. Jürgenliemk-Schulz, Chris H. J. Terhaard, Jan W. Koten, Jan J. Battermann, Willem Den Otter

Original Article

Safety evaluation of DT388IL3, a diphtheria toxin/interleukin 3 fusion protein, in the cynomolgus monkey

Kimberley A. Cohen, Tie Fu Liu, J. Mark. Cline, Janice D. Wagner, Philip D. Hall, Arthur E. Frankel

Original Article

Lysophosphatidic acid stimulates fas ligand microvesicle release from ovarian cancer cells

Yuru Meng, Shijun Kang, David A. Fishman

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine